MAC Clinical Research- Manchester

Manchester M13 9NQ

0 studies enrolling now · 10 studies all time

What they study most

Adjunctive Treatment of Major Depressive Disorder, Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer Disease, Dementia-related Psychosis, Gastroparesis, Irritable Bowel Syndrome, Pouchitis, Psoriasis

Studies at this site

• Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis — Running, not enrolling
• Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type — Completed
• An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis — Completed
• Study of the Safety and Efficacy of AMT-101 in Subjects With Pouchitis — Completed
• Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment — Stopped early
• A Trial for New Treatment of Adult Participants With Irritable Bowel Syndrome — Completed
• Diabetic Gastroparesis Study 05 — Stopped early
• Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment — Completed
• Proof-of-Concept Study of a Selective p38 MAPK Alpha Inhibitor, Neflamapimod, in Subjects With Mild Alzheimer's Disease — Completed
• Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis — Completed